Skip to main content Accessibility help
×
Hostname: page-component-77c89778f8-vpsfw Total loading time: 0 Render date: 2024-07-17T01:58:49.869Z Has data issue: false hasContentIssue false

6 - Tuberous sclerosis complex

Published online by Cambridge University Press:  31 July 2009

E. Steve Roach
Affiliation:
Department of Neurology, Wake Forest University School of Medicine, Winston–Salem, NC, USA
E. Steve Roach
Affiliation:
Wake Forest University, North Carolina
Van S. Miller
Affiliation:
University of Texas Southwestern Medical Center, Dallas
Get access

Summary

Introduction

Tuberous sclerosis complex (TSC) is a dominantly inherited disorder, which affects the brain, skin, heart, lungs, kidneys, and other organs (Roach et al., 1998). Many of the clinical manifestations of TSC result from hamartomas of these organs, and abnormal neuronal migration plays a major additional role in neurologic dysfunction (Sparagana & Roach, 2000). Because of its striking variability of clinical expression and severity, the diagnosis of TSC can be difficult in individuals with subtle findings. The clinical diagnostic criteria were recently revised (Table 6.1). Population-based studies suggest a prevalence of 1 per 6000 to 9000 individuals (Osborne et al., 1991).

Clinical manifestations

Skin lesions

The cutaneous lesions of TSC include hypomelanotic macules (‘ash leaf spots’), the shagreen patch, facial angiofibromas (‘adenoma sebaceum’), and ungual fibromas (Roach & Delgado, 1995). Hypomelanotic macules are found in over 90% of patients (Fig. 6.1); poliosis of the scalp hair or eyelids occur less often. The lesions are usually present at birth but can be difficult to see in the newborn without an ultraviolet light. Hypomelanotic macules are not specific for TSC: one or two of these lesions sometimes occur in normal individuals (Vanderhooft et al., 1996).

Facial angiofibromas contain both vascular and connective tissue elements. These lesions are found in about three-fourths of patients and typically become apparent during the preschool years as small red papules on the malar region (Roach & Delgado, 1995). They gradually become larger and more numerous, sometimes extending down the nasolabial folds or onto the chin (Fig. 6.1).

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bjornsson, J., Short, M. P., Kwiatkowski, D. J. & Henske, E. P. (1996). Tuberous sclerosis-associated renal cell carcinoma. Clinical, pathological, and genetic features. American Journal of Pathology, 149: 1201–1208Google ScholarPubMed
DiMario, F. J., Diana, D., Leopold, H. & Chameides, L. (1996). Evolution of cardiac rhabdomyoma in tuberous sclerosis complex. Clinical Pediatrics, 12: 615–619CrossRefGoogle Scholar
Dwyer, J. M., Hickie, J. B. & Garvan, J. (1971). Pulmonary tuberous sclerosis. Report of three patients and a review of the literature. Quarterly Journal of Medicine, 40: 115–125Google Scholar
Ewalt, D. E., Sheffield, E., Sparagana, S. P., Delgado, M. R. & Roach, E. S. (1998). Renal lesion growth in children with tuberous sclerosis complex. Journal of Urology, 160: 141–145CrossRefGoogle ScholarPubMed
Fleury, P., Groot, W. P., Delleman, J. W., Verbeeten, B. Jr. & Frankenmolen-Witkiezwicz, I. M. (1980). Tuberous sclerosis: the incidence of sporadic cases versus familial cases. Brain Development, 2: 107–117CrossRefGoogle ScholarPubMed
Gillberg, I. C., Gillberg, C. & Ahlsen, G. (1994). Autistic behavior and attention deficits in tuberous sclerosis: a population-based study. Developmental Medicine and Child Neurology, 36: 50–56CrossRefGoogle ScholarPubMed
Goodman, M., Lamm, S. H., Engel, A., Shepherd, C. W. & Gomez, M. R. (1997). Cortical tuber count: a biomarker indicating cerebral severity of tuberous sclerosis complex. Journal of Child Neurology, 11: 85–90CrossRefGoogle Scholar
Hunt, A. & Dennis, J. (1987). Psychiatric disorders among children with tuberous sclerosis. Developmental Medicine and Child Neurology, 29: 190–198CrossRefGoogle ScholarPubMed
Jones, A. C., Shyamsundar, M. M., Thomas, M. W. et al. (1999). Comprehensive mutation analysis of TSC1 and TSC2 and phenotypic correlations in 150 families with tuberous sclerosis. American Journal of Human Genetics, 64: 1305–1315CrossRefGoogle ScholarPubMed
Jozwiak, S., Goodman, M. & Lamm, S. H. (1998). Poor mental development in patients with tuberous sclerosis complex. Clinical risk factors. Archives in Neurology, 55: 379–384CrossRefGoogle ScholarPubMed
Kiribuchi, K., Uchida, Y., Fukuyama, Y. & Maruyama, H. (1986). High incidence of fundus hamartomas and clinical significance of a fundus score in tuberous sclerosis. Brain Development, 8: 509–517CrossRefGoogle ScholarPubMed
Lenoir, S., Grenier, P., Brauner, M. W. et al. (1990). Pulmonary lymphangiomyomatosis and tuberous sclerosis: comparison of radiographic and thin-section CT findings. Radiology, 175: 329–334CrossRefGoogle ScholarPubMed
Miller, V. S. & Roach, E. S. (2000). Neurocutaneous Syndromes. In Neurology in Clinical Practice, 3rd edn, ed. W. Bradley, R. B. Daroff, G. M. Fenichel & C. D. Marsden. Boston: Butterworth–Heinemann
Osborne, J. P., Fryer, A. & Webb, D. (1991). Epidemiology of tuberous sclerosis. Annals of the New York Academy of Science, 615: 125–127CrossRefGoogle ScholarPubMed
Roach, E. S. (1988). Diagnosis and management of neurocutaneous syndromes. Seminars in Neurology, 8: 83–96CrossRefGoogle ScholarPubMed
Roach, E. S. (1992). Neurocutaneous syndromes, Pediatric Clinics of North America, 39: 591–620CrossRefGoogle ScholarPubMed
Roach, E. S. & Delgado, M. R. (1995). Tuberous sclerosis. Dermatology Clinics, 13: 151–161Google ScholarPubMed
Roach, E. S., Williams, D. P. & Laster, D. W. (1987). Magnetic resonance imaging in tuberous sclerosis. Archives of Neurology. 44: 301–303CrossRefGoogle ScholarPubMed
Roach, E. S., Kerr, J., Mendelsohn, D., Laster, D. W. & Raeside, C. (1991). Diagnosis of symptomatic and asymptomatic gene carriers of tuberous sclerosis by CCT and MRI. Annals of the NY Academy of Science, 615: 112–122CrossRefGoogle ScholarPubMed
Roach, E. S., Gomez, M. R. & Northrup, H. (1998). Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. Journal of Child Neurology, 13: 624–628CrossRefGoogle ScholarPubMed
Roach, E. S., DiMario, F. J., Kandt, R. S. & Northrup, H. (1999). Tuberous sclerosis consensus conference: recommendations for diagnostic evaluation. Journal of Child Neurology, 14: 401–407CrossRefGoogle ScholarPubMed
Rose, V. M., Au, K. -S., Pollom, G., et al. (1999). Germ-line mosaicism in tuberous sclerosis; how common? American Journal of Human Genetics, 64: 986–992CrossRefGoogle ScholarPubMed
Scully, R. E., Mark, E. J., McNeely, W. F. & McNeely, B. V. (1994). Case records of the Massachusetts General Hospital–Case 18–1994. New England Journal of Medicine, 330: 1300–1306Google Scholar
Shepherd, C. W., Scheithauer, B. W., Gomez, M. R., Altermatt, H. J. & Katzmann, J. A. (1991). Subependymal giant cell astrocytoma: a clinical, pathological, and flow cytometric study. Neurosurgery, 28: 864–868CrossRefGoogle ScholarPubMed
Shepherd, C. W., Houser, O. W. & Gomez, M. R. (1995). MR findings in tuberous sclerosis complex and correlation with seizure development and mental impairment. American Journal of Neuroradiology, 16: 149–155Google ScholarPubMed
Sparagana, S. P. & Roach, E. S. (2000). Tuberous sclerosis complex. Current Opinion in Neurology, 13: 115–119CrossRefGoogle ScholarPubMed
Steiner, M. S., Goldman, S. M., Fishman, E. K. & Marshall, F. F. (1993). The natural history of renal angiomyolipoma. Journal of Urology, 150: 1783–1786CrossRefGoogle ScholarPubMed
Torres, O. A., Roach, E. S., Delgado, M. R. et al. (1998). Early diagnosis of subependymal giant cell astrocytoma in patients with tuberous sclerosis. Journal of Child Neurology, 13: 173–177CrossRefGoogle ScholarPubMed
Slegtenhorst, M., Hoogt, R., Hermans, C., Nellist, M., Janssen, B. & Verhoef, S. (1997). Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science, 277: 805–808CrossRefGoogle ScholarPubMed
Slegtenhorst, M., Nellist, M., Nagelkerken, B. et al. (1998). Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Human Molecular Genetics, 7: 1053–1057CrossRefGoogle ScholarPubMed
Vanderhooft, S. L., Francis, J. S., Pagon, R. A., Smith, L. T. & Sybert, V. P. (1996). Prevalence of hypopigmented macules in a healthy population. Journal of Pediatrics, 129: 355–361CrossRefGoogle Scholar
Verhoef, S., Bakker, L., Tempelaars, A. M. P. et al. (1999). High rate of mosaicism in tuberous sclerosis. American Journal of Human Genetics, 64: 1632–1637CrossRefGoogle ScholarPubMed
Webb, D. W., Fryer, A. E. & Osborne, J. P. (1991). On the incidence of fits and mental retardation in tuberous sclerosis. Journal of Medical Genetics, 28: 395–397CrossRefGoogle ScholarPubMed
Weiner, D. M., Ewalt, D. E., Roach, E. S. & Hensle, T. W. (1998). The tuberous sclerosis complex: a comprehensive review. Journal of the American College of Surgery, 187: 548–561CrossRefGoogle ScholarPubMed
Wienecke, R., Maize, J. C., Reed, J. A., Ganzburg, J., Yeung, R. S. & DeClue, J. E. (1997). Expression of the TSC2 product tuberin and its target rap1 in normal human tissues. American Journal of Pathology, 150: 43–50Google ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Tuberous sclerosis complex
    • By E. Steve Roach, Department of Neurology, Wake Forest University School of Medicine, Winston–Salem, NC, USA
  • Edited by E. Steve Roach, Wake Forest University, North Carolina, Van S. Miller, University of Texas Southwestern Medical Center, Dallas
  • Book: Neurocutaneous Disorders
  • Online publication: 31 July 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545054.008
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Tuberous sclerosis complex
    • By E. Steve Roach, Department of Neurology, Wake Forest University School of Medicine, Winston–Salem, NC, USA
  • Edited by E. Steve Roach, Wake Forest University, North Carolina, Van S. Miller, University of Texas Southwestern Medical Center, Dallas
  • Book: Neurocutaneous Disorders
  • Online publication: 31 July 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545054.008
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Tuberous sclerosis complex
    • By E. Steve Roach, Department of Neurology, Wake Forest University School of Medicine, Winston–Salem, NC, USA
  • Edited by E. Steve Roach, Wake Forest University, North Carolina, Van S. Miller, University of Texas Southwestern Medical Center, Dallas
  • Book: Neurocutaneous Disorders
  • Online publication: 31 July 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545054.008
Available formats
×